Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
AssigneeThe Procter & Gamble Company
InventorsGary Robert Kelm, Koji Kondo, Akio Nakajima
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Procter & Gamble Company
InventorsGary Robert Kelm, Koji Kondo, Akio Nakajima
Estimating the term…
The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine, comprising: a. a safe and effective amount of rapidly dissolving bisacodyl incorporated into a compressed, bi-convex tablet, with a maximum diameter of about 4 mm to about 10 mm; b. a non-pH dependent smoothing coat applied to the tablet to provide a smooth tablet surface free from edges and sharp curves; and c. an enteric polymer coating material comprising at least one inner coating layer and only one outer coating layer; wherein the rapidly dissolving bisacodyl is released at a point near the inlet to, or within the colon; each of the inner coating layer(s) is an enteric polymer that begins to dissolve in an aqueous media at a pH between about 5 to about 6.3; and the outer coating layer is an enteric polymer that begins to dissolve in an aqueous media at a pH between about 6.8 to about 7.2.
A compressed, bi-covex tablet for peroral administration in a human or other animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine comprising:
Dependencies are inferred from the claim text.